Welcome to the Neurodegeneration Imaging Group
The Neurodegeneration Imaging Group (NIG) is headed by Marios Politis and primarily focuses in the use of Positron Emission Tomography (PET) molecular imaging, Magnetic Resonance Imaging (MRI), and Clinical observation to study common (Parkinson’s disease, Alzheimer’s disease, Multiple Sclerosis) and less common (Huntington’s disease, Multiple System Atrophy, Progressive Supranuclear Palsy, Corticobasal degeneration) neurodegenerative disorders.
NIG develops and establishes a range of new projects and approaches for investigating aetiology, pathophysiology, diagnosis, progression, and identification of novel molecular targets for pharmacotherapy in neurodegenerative disorders. Our studies commonly involve PET and MR imaging together with clinical observation. We are very interested in brain response to conventional, novel and restorative treatment.
We have a rapidly expanding work portfolio, team and collaborative agenda, and we are looking to accommodate several levels of clinical and non-clinical research staff. As part of our large ongoing research in the field of neurodegenerative disorders we have capacity to accommodate academic visiting appointments for periods of up to 24 months.
Without the generosity of people and funding bodies our research would not be possible. Donations help us to make a real difference in the lives of people affected by neurodegenerative disorders. Funding support enables us to work towards achieving our ultimate ambition – to get closer to a cure, and improve life for everyone affected by neurodegenerative disorders. Please contact us if you would like to fund our academic research.